How big is the Oligonucleotide Synthesis Market?

The Oligonucleotide Synthesis Market size is expected to reach USD 3.42 billion in 2024 and grow at a CAGR of 12.34% to reach USD 6.12 billion by 2029. Read More

What is the current Oligonucleotide Synthesis Market size?

In 2024, the Oligonucleotide Synthesis Market size is expected to reach USD 3.42 billion. Read More

Who are the key players in Oligonucleotide Synthesis Market?

Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Bio-Synthesis Inc and Eurofins Scientific are the major companies operating in the Oligonucleotide Synthesis Market. Read More

Which is the fastest growing region in Oligonucleotide Synthesis Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Oligonucleotide Synthesis Market?

In 2024, the North America accounts for the largest market share in Oligonucleotide Synthesis Market. Read More

What years does this Oligonucleotide Synthesis Market cover, and what was the market size in 2023?

In 2023, the Oligonucleotide Synthesis Market size was estimated at USD 3.00 billion. The report covers the Oligonucleotide Synthesis Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oligonucleotide Synthesis Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

What are the key challenges faced in the Oligonucleotide Synthesis Market?

The key challenges faced in the Oligonucleotide Synthesis Market are a) Strict regulations governing the safety and efficacy of oligonucleotides can create hurdles for market entry and extend development timelines b) Advancements in other gene editing or therapeutic technologies may pose competition for oligonucleotide-based therapies Read More

What are the key challenges faced in the Oligonucleotide Synthesis Market?

The key challenges faced in the Oligonucleotide Synthesis Market are a) Strict regulations governing the safety and efficacy of oligonucleotides can create hurdles for market entry and extend development timelines b) Advancements in other gene editing or therapeutic technologies may pose competition for oligonucleotide-based therapies Read More

Oligonucleotide SynthesisCompanies

This report lists the top Oligonucleotide Synthesis companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Oligonucleotide Synthesis industry.